NCT05199584 2026-03-05A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsEndeavor Biomedicines, Inc.Phase 2 Completed20 enrolled
NCT06872489 2025-07-23Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid TumorsSecond Life TherapeuticsAvailable